Tuesday
July 29, 2025
6:48 AM ET
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Second Quarter 2025
Monday
July 28, 2025
4:01 PM ET
Fulcrum Therapeutics to Present Results from the 12 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease
Thursday
May 1, 2025
7:00 AM ET
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2025
Thursday
April 24, 2025
8:00 AM ET
Fulcrum Therapeutics to Host First Quarter 2025 Financial Results Conference Call and Webcast on Thursday, May 1, 2025, at 8:00 a.m. ET
Tuesday
February 25, 2025
7:00 AM ET
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2024